(3-bromo-2,5-dimethoxy-phenyl)-acetic acid | 551001-65-1

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: (3-bromo-2,5-dimethoxy-phenyl)-acetic acid
• 英文别名: (3-Brom-2,5-dimethoxy-phenyl)-essigsaeure；2-(3-bromo-2,5-dimethoxyphenyl)acetic acid
• CAS: 551001-65-1
• 化学式: C₁₀H₁₁BrO₄
• 分子量: 275.099
• InChiKey: AULAHKHPLCIVKU-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2
• 重原子数：
  15
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.3
• 拓扑面积：
  55.8
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  (3-bromo-2,5-dimethoxy-phenyl)-acetic acid 在 三氯化铝 、 氯化亚砜 、 吡啶溴化氢盐 、 copper(I) bromide 作用下， 以 二氯甲烷 为溶剂， 生成 2-(3-Fluoro-4-hydroxy-phenyl)-7-methoxy-benzofuran-5-ol
  参考文献：
  名称：

  7-Substituted 2-phenyl-benzofurans as ERβ selective ligands

  摘要：

  A series of 2-(4-hydroxy-phenyl)-benzofuran-5-ols with relatively lipophilic groups in the 7-position of the benzofuran was prepared and the affinity and selectivity for ERbeta was measured. Many of the analogues were found to be potent and selective ERbeta ligands. Additional modifications at the benzofuran 4-position as well as at the 3'-position of the 2-phenyl group were found to further increase selectivity. Such modifications led to compounds with <10nM potency and >100-fold selectivity for ERbeta. (C) 2004 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2004.07.029
• 作为产物：
  描述：

  (3-bromo-2,5-dimethoxy-phenyl)-acetonitrile 在 conc H₂SO₄ 、 溶剂黄146 作用下， 以 水 、 乙酸乙酯 为溶剂， 以55%的产率得到(3-bromo-2,5-dimethoxy-phenyl)-acetic acid
  参考文献：
  名称：

  Substituted 2-phenyl benzofurans as estrogenic agents

  摘要：

  这项发明提供了具有结构1的式I的雌激素受体调节剂，其中R、R'、A、A'、X、Y和Y如规范中定义，或其药用可接受盐。

  公开号：

  US20030171428A1

文献信息

• Tetracyclic compounds as estrogen ligands
  申请人：Miller P. Christopher

  公开号：US20060004087A1

  公开（公告）日：2006-01-05

  This invention provides estrogen receptor modulators having the structure: wherein R 1 , R 2 , R 3 , R 4 , Q, n, R 8 , R 9 , R 10 , and R 11 have been defined in the specification; or a pharmaceutically acceptable salt thereof. The invention further provides methods for the preparation and use of the compounds.

  这项发明提供了具有以下结构的雌激素受体调节剂：其中R1、R2、R3、R4、Q、n、R8、R9、R10和R11已在规范中定义；或其药用盐。该发明还提供了该化合物的制备和使用方法。
• PHARMACEUTICAL COMPOSITIONS AND METHODS OF PREVENTING, TREATING, OR INHIBITING INFLAMMATORY DISEASES, DISORDERS, OR CONDITIONS OF THE SKIN, AND DISEASES, DISORDERS, OR CONDITIONS ASSOCIATED WITH COLLAGEN DEPLETION
  申请人：CHANG Chien-Neng

  公开号：US20090010884A1

  公开（公告）日：2009-01-08

  The present invention provides compositions and methods for preventing, treating, or inhibiting inflammatory diseases, disorders, or conditions of the skin, and diseases, disorders, or conditions associated with collagen depletion using one or more estrogenic agents.

  本发明提供了使用一个或多个雌激素类药物预防、治疗或抑制皮肤炎症性疾病、紊乱或状况以及与胶原蛋白流失相关的疾病、紊乱或状况的组合物和方法。
• Substituted 2-phenyl benzofurans as estrogenic agents
  申请人：Wyeth

  公开号：US20030171428A1

  公开（公告）日：2003-09-11

  This invention provides estrogen receptor modulators of formula I, having the structure 1 wherein R, R′, A, A′, X, Y, and Y are as defined in the specification, or a pharmaceutically acceptable salt thereof.

  这项发明提供了具有结构1的式I的雌激素受体调节剂，其中R、R'、A、A'、X、Y和Y如规范中定义，或其药用可接受盐。
• Ketene Acetals. XIV. The Reactions of Ketene Acetal with Quinones
  作者：S. M. McElvain、Edward L. Engelhardt

  DOI：10.1021/ja01235a006

  日期：1944.7
• SUBSTITUTED 2-PHENYL BENZOFURANS AS ESTROGENIC AGENTS
  申请人：Wyeth

  公开号：EP1458700A2

  公开（公告）日：2004-09-22